| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.6 |